Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 JUN 1 ... and Prevention, the World Health Organization and other health groups note that GSK's Relenza is effective against the 2009 strain of A (H1N1) flu virus, often called swine flu.
...
2009 SEP 21 ... of California also provides prescription drug coverage for Tamiflu (oseltamivir) and Relenza (zanamivir) -- the two anti-viral drugs used to treat flu symptoms. The company has ...
2009 OCT 19 ... demonstrated by a packaging launch involving GlaxoSmithKline's anti-viral product Relenza®, which has been recommended by a number of global health authorities for treatment ...
2009 NOV 2 ... to the global pandemic, it was necessary to rapidly expand manufacture and supply of Relenza®, a major antiviral product," said Jim Brown, Director, External Supply ...
2009 MAY 25 ... the opportunity to distribute counterfeit anti-influenza drugs, such as Tamiflu and Relenza.
"The Partnership for Safe Medicines (PSM) reminds consumers that ...
2009 NOV 1 ... and prophylaxis of the 2009 H1N1 influenza virus are Tamiflu (oseltamivir phosphate) and Relenza (zanamivir). Tamiflu and Relenza, in ...
2009 NOV 2 ... and prophylaxis of the 2009 H1N1 influenza virus - Tamiflu (oseltamivir phosphate) and Relenza (zanamivir). Tamiflu and Relenza, in addition to their ...
2009 AUG 3 ... in pandemic vaccine orders. So H1N1 or Swine 'Flu. We'll also see increased volumes of Relenza, our antiviral, being shipped as well as the kick-in of a series of new products." ...
2009 NOV 16 ... with each manufacturer over two years. Roche manufactures Tamiflu; GlaxoSmithKline, Relenza, and BioCryst manufactures Peramivir. Because there are no Food and Drug ...
Subject: U.S. Department of Health and Human Services
2009 NOV 9 ... IkT-041, comparable in activity to viral neuraminidase inhibitors (e.g. Tamiflu, Relenza), but one that is far less likely to stimulate resistance. IkT-041 has excellent human ...
2009 NOV 23 ... increasing prevalence of drug resistance to Tamiflu=AE, and the other NAI on the market, Relenza=AE, is contraindicated for this population." said Dr. Moss. Keywords: ...
2009 JUN 29 ... Medical Association Journal) reports that oseltamivir (Tamiflu®) and zanamivir (Relenza®) are relatively safe drugs for use in pregnant and breast-feeding women.
...
2009 OCT 19 ... flu-related items. Stores also are stocked with the prescription medications Tamiflu and Relenza for those patients whose doctor has recommended they take one of these medications or ...
2009 MAY 19 ... and treatment, write prescriptions for anti-viral medications such as Tamiflu and Relenza as clinically necessary and triage patients to other sources of care. At some locations ...
2009 JUN 1 ... Standard therapy for the disease includes treatment with antiviral drugs like Tamiflu or Relenza. For more information on Influenza A H1N1 please visit www.who.int. About Roche ...
2009 NOV 2 ... week ending Oct. 16, up 37% from just over 367,000 the week before. Prescriptions for Relenza increased 24%, from approximately 6,600 in the week ending Oct. 9 to approximately 8,200 ...
2009 OCT 19 ... examines the extensive stockpiling of vaccines and antiviral drugs (such as Tamiflu and Relenza) and their widespread distribution for preventive use at the onset of a local outbreak. ...
2009 OCT 5 ... increase access to the H1N1 vaccine. In addition, the antiviral medications Tamiflu and Relenza will move to an economical tier in plan formularies. The CDC has ...
2009 JUN 1 ... will be the Institute of Cancer Research and AstraZeneca. GlaxoSmithKline, that makes Relenza, one of the two top antivirals used against swine flu, will also be present.
...
